Month: September 2011

It protects your baby with new wipes Difrax

It protects your baby with new wipes Difrax

|

protects your baby with new wipes Difrax

Madrid, 2011-September Difrax, leading Dutch brand in the field of childcare in Europe, presents its new hygienic wipes developed specially for the cleaning of products which are in contact with the appetizers of the children; such as pacifiers, teats and small toys (teethers).

Difrax wipes have no odour or taste, so it allows a cleaning and disinfection of the pacifier or toy without the baby note. The formula consists of Chlorhexidine Digluconato, Glycerina, Phenoxyethanol, Polyglyceryl-4, Caprate, lactic acid and water.

These wipes are perfect when you are away from home, walk or travel, and you need to remove the dirt of the nipple, teat or toys, caused by the transport bags, friction with other products or any unforeseen. Its function of cleaning and disinfection leaves any element that the baby could lead to his mouth free of viruses and bacteria.

Thanks to them, moms and dads can feel more relaxed if the soother falls to the ground or the bite goes hand in hand, you can clean and use without worries.

The package of wipes have 20 units and its price is 5.20 euros.

On Free Pharma Europe

the laboratory Free Pharma Europe was born more than 10 years ago with the purpose of marketing its own brands and also working as a distributor of other prominent companies, both in Spain as internationally.

Free Pharma Europe work in the fields of health, nutrition, Pediatrics, and cosmetic, marketing products of high quality, advanced technical development and high added value to our distributors and consumers.

All brands marketed by Free Pharma Europe evokes an exclusive image designed for those consumers with the highest expectations.

Free Pharma products are sold in pharmacies, parapharmacies and cosmetic centers, are promoted by a team of highly qualified professionals and a national and international commercial network.

Free Farma has managed to position itself as a laboratory which is identified by continuous innovation. Proud of the beaten path, this young Spanish company is facing a great future.

Read More

Copper is a trace element essential for the prevention of osteoporosis

|

copper is an essential for the prevention of osteoporosis trace element

copper prevents bone diseases such as osteoporosis

-copper influences decisively bone strength, preventing diseases like osteoporosis.

-A diet composed of copper-rich foods such as chocolate, cereals or seafood increases the level of copper in the body.

-copper is a trace element essential for the correct development of the fetus during pregnancy.

Madrid, September of 2011. Bone diseases are a problem that primarily affects the elderly. With the passage of time, people lose bone density at more risk of injury or serious fractures. Osteoporosis is the most common bone disease, which is produced by a decrease in the amount of minerals in bones. This disease is common among elderly and postmenopausal women. The lack of calcium and minerals in the diet is one of the main causes of this disease.

Copper is a mineral essential to the human body. It ensures the normal functioning of the brain, the nervous system and the cardiovascular system, and also transports iron, helps the growth of bones and strengthens the immune system. A copper-rich diet may help prevent osteoporosis, as well as other diseases such as anemia, rheumatoid arthritis and cardiovascular disease. Studies show that the majority of the elderly who suffer any fracture in bones have levels of copper in blood lower than the recommended for their age.

According to various studies, about 30% of Western diets are deficient in copper, which is damaging to our bone system. Follow a diet rich in copper is not difficult, because this mineral is found in drinking water and many foods that we consume on a daily basis, such as chocolate, cereals, vegetables, seafood, nuts, or liver. Following a diet balanced with this type of food, we will always reduce the risk of fractures or bone problems.

The World Health Organization recommends an intake of copper 1, 3-1, 5 milligrams per day for adults and also establishes that a daily intake of copper between 1 and 11 mg, is safe for adults. The real intake of copper ranges between 0.6 and 2 mg per day, which suggests that a deficiency of copper in the usual diet may be worrying for health.

Other diseases

Bone problems aren’t the only ones that can arise in the absence of copper. Anemia (very common disease among women who have recently given birth), neutropenia (reduction of neutrophil in leukocytes count) or anatomical changes detrimental to health as muscular degeneration or arthritis. The lack of copper impairs the metabolism of cholesterol: a deficit of this mineral increases LDL (bad cholesterol) levels and reduce the levels of HDL (good cholesterol). Low copper levels also lead to adverse effects in the process of glucose metabolism and blood circulation.

Another problem related to the shortage of copper in the body is the disease of Menkes, an inherited disorder of metabolism of copper resulting in a lack of this mineral in the body, eventually causing irreversible damage. The problem lies in the absence of one of the genes responsible for transporting copper, which prevents the cells of the intestine to have necessary copper for the proper functioning of the body.

On the Spanish copper information centre (CEDIC):

CEDIC is a professional association of companies in the basic of the copper industry in Spain that develops an essentially informative activity in two different aspects. On the one hand it promotes and supports studies or research aimed at improving the techniques of obtaining, processing and use of copper. On the other hand, it brings together all the documentation produced in Spain and in other countries, concerning the copper to publicize her.

In this line, CEDIC has established a relationship of mutual cooperation with organizations public or private, national or foreign, with parallel to their own objectives. Among others, the International Copper Association (ICA), headquartered in New York, the European Copper Institute (ECI), based in Brussels, in addition to other twenty-three similar to CEDIC centres distributed throughout the world, eleven of them in Europe.

Read More

The lack of attention is the main cause of accidents at work.

|

the lack of attention is the leading cause of work-related accidents.

Spain, 2011-September according to a poll national working conditions, the most important risks encountered by workers to develop their work, with the main causes of accidents have been compared. For this study were asked workers what believed that they were the three factors of most important risks in occupational accidents. The table of results was firstly the lack of attention, with 45% of the views. Secondly, they placed the speed with which perform the tasks, with a 19.4%. Tiredness and fatigue, were in third place, with 17.8% of the results. 12.5% Of the votes placed the traffic as the fourth most important risk factor. In the fifth and sixth place we find forced positions, and the openings or gaps unprotected. Late position those concerned with the lack of information, and not be qualified for the work done.

The reality on the root causes of accidents at work shows that the lack of attention and the distractions are the first cause of accidents, causing these forgetfulness 19.3 per cent of the accidents. Second place occupy forced postures and the instant, causing these 15.4% of the incidents. Third place is situated the situations related to traffic, while the fourth factor causing more accidents is tiredness or fatigue.

In the event that an accident will cause serious anatomical or functional cuts that reduce or annul the working capacity of the worker, the person will be able to be declared incapacitated permanently, so it is entitled to receive a Social Security pension. Contrary to common disease, the beneficiary not is required no contribution period and is entitled to 100% of your base figure.

To achieve this Declaration of permanent disability, it is essential to put in the hands of specialists. Cabinet technical medical legal is the only medical and legal Center of Spain specializes in pensions, social security and compensation, and has more than 35 years of experience in the processing of these. An initial medical assessment with a medical team experienced, where the damage and the degree of disability is deemed to claim, is the best guarantee to gain access to a permanent disability pension.

Read More

Bioiberica leads a study to predict the evolution of arthritis from a saliva sample

|

Bioiberica leads a study to predict the evolution of arthritis from a saliva sample

Congress World of ARTHROSIS (OARSI)

-Francisco j. Blanco Garcia, rheumatologist complex Hospitalario Universitario A Coruña, introduced the draft “ Arthrosischip ”, to predict the evolution of arthrosis

-Bioiberica is the only Spanish pharmaceutical that participates in the 2011 OARSItwo symposia on the treatment of chronic arthritis and personalized medicine

-Barcelona will host the 2012 OARSI, with the collaboration of Bioiberica

Barcelona, 2011-September know how will evolve the osteoarthritis of knee with a simple saliva test could be a reality in the future. Thus present it Bioiberica in the world osteoarthritis Congress (OARSI) to be held in San Diego, California on 15-18 September.

Dr. Francisco j. Blanco, complex Hospitalario Universitario A Coruña rheumatologist, will be in charge of presenting the “ Arthrosischip ” during the Symposium of “ medicine custom ” organized by Bioiberica. This innovative research project seeks to develop a gene chip that can predict the progression of osteoarthritis of the knee in patients diagnosed with this disease. Based on the technology of DNA microarrays, Arthrosischip shall consist of a genetic analysis from a saliva sample. It will identify genetic mutations associated with the evolution of arthritis and clinical data, basically, risk factors such as sex or concomitant diseases of arthritis such as diabetes. It is a study jointly developed between Bioiberica, company with more than 30 years of experience in health of joints and leader in chondroprotection, and Progenika, specialist in the design and development of tools for personalized medicine.

Part of the project “ Arthrosischip ”, Dr. Allen Sawitzke of the Faculty of Medicine of the University of Utah, United States, will present the second phase of the project that aims to identified using biological markers and on the basis of a preliminary analysis of genetic inheritance, those patients with osteoarthritis more susceptible to rapid progress in his illness, and therefore to end up in implementation of prosthesis. This study is carried out in collaboration between Bioiberica, the University of Utah and the National Institute of Health (NIH).

Dr. Thomas Pap, University Hospital of Münster, Germany, will close the Symposium with a review of the biomarkers in osteoarthritis and its usefulness in the diagnosis, prognosis, description of the severity of the disease and analysis of the effectiveness of an intervention. The objective of this symposium is to demonstrate how personalized medicine can offer a wide range of possibilities to the patient with arthrosis, incapacitated from chronic, and often dealt with only in certain episodes of the disease. Personalized medicine can help both in its prevention and control of the progression once appeared pathology.

Effectiveness of chondroitin sulfate on osteoarthritis how arthritis has gone from being exclusively a pathology of cartilage to a pathology of “ the entire joint ” will be the premise that opens another Symposium Bioiberica has organized and which bears the name “ in osteoarthritis symptom Control: evidence with drugs for symptomatic slow action ”. One of the speakers will be Professor Jean-Pierre Pelletier, Director of the research unit in arthrosis of the Université de Montréal (Canada) and principal investigator of a recent clinical trial conducted with chondroitin sulfate in patients with osteoarthritis of the knee and evaluated by nuclear magnetic resonance. Prof. Pelletier will carry out a review of various clinical trials and meta-analysis published with chondroitin sulfate in order to assess their efficacy and safety for the treatment of osteoarthritis of the knee. These studies allow to conclude that chondroitin sulfate is a symptomatic slow action drug effective in the treatment of arthritis with an excellent safety profile. The condroprotectores, and in particular the chondroitin sulfate, are drugs that act directly on the three joint structures affected by osteoarthritis: joint cartilage, synovial membrane, and the subcondral bone. They not only relieve the symptoms of osteoarthritis, but it is proving have ability to attack the root disease, slowing down the degenerative process that takes place in the joints, primarily of hands, hips, knees, etc.

The OARSI in Barcelona in April 2012 with Bioiberica as main sponsor, the next edition of OARSI be held in Barcelona in April. During these days will gather in the city more than one thousand of specialists from around the world, including rheumatologists, researchers, orthopaedic surgeons, radiologists, clinical and other stakeholders in the research of arthritis. However, this Congress has the most prestigious professionals dedicated to the treatment of arthritis to share progress and experiences in the investigation of this disease.

Bioiberica Farma

Bioiberica Farma is the only Spanish laboratory specializing in research and development of effective drugs for the treatment of osteoarthritis. Specifically, specialises in chondroprotection, namely, prevention, diagnosis and treatment of cartilage, synovial membrane, and the subcondral bone injuries.

This expertise in the treatment of osteoarthritis has helped Bioiberica Farma occupies a leading position endorsed by numerous published clinical trials, research projects underway, the recognition of different societies scientific and medical, strict quality control chemical and biological production processes, the quality of their products and editing of publications specialised in chondroprotection.

Read More

NASA presents a new launch system that will be the man to Mars

|

Washington, 14 sep (EFE).-La NASA today introduced the new system of space launch that wants to put at the head of the exploration of space and achieve new goals such as the first manned trip to an asteroid and the cherished trip to Mars.

These new destinations mean leave low Earth orbit and venture into more deep space something that NASA intends to do for the first time with ships manned.

The date is not so distant, as according to the plan presented by President Barack Obama last year is expected to reach an asteroid by 2025 and send the first mission to the red planet in 2030.

With the new system of release, the strongest so far since the Saturn V that reached the moon mission crew Apollo more than 40 years ago, is one step closer, said the director of the NASA, Charles Bolden.

“We are investing in technologies to live and work in space, and setting the stage for visit asteroids and Mars,” asserted.

After months of studying various plans and designs, Bolden presented along with several members of Congress the Administration Obama plan for designing rocket system launch space (SLS, for its acronym in English).

“This new launch system will create good jobs in United States and will ensure US space leadership,” said Bolden.

The President Obama “has challenged us to be daring to dream big, and that is exactly what we are doing at NASA,” said Bolden.

This project, he said, would begin a new era in space exploration “will inspire millions of people around the world”.

With this decision culminate months of debate to tell NASA with a launch system not only powerful, but versatile, allowing to adapt new technologies to the needs that arise.

The rocket is designed to move to the astronauts in a capsule Orion installed on the top, as well as large quantities of cargo, equipment and experiments to Earth orbit and other more distant destinations, and will serve as support for the transport ships trading to be carried out flights of cargo and replacement of astronauts to the international space station (ISS).

Will have an initial capacity of 70 tons, capable of elevating the capsule with six crew members, and expand to the 130. Later is expected to be reached between 140 and 165 tons.

Used liquid hydrogen and oxygen as fuel, also will be powered by engines RS-25D/E and the upper stages engines J2X. NASA plans to start tests of launch in 2017.

After the cancellation of the constellation program and the withdrawal of the space shuttle in July, NASA ran out own launch vehicle, but this new heavy-lift rocket will be the “key” for the implementation of the plan drawn up by the Obama President and the Congress under the NASA Authorization Act of last year, said Bolden.

“Once resolved the architecture of the heavy-lift launch system, NASA can now go ahead with the construction of the rocket, and a new generation of vehicles and technologies necessary for an ambitious programme of manned deep space missions”, said in a statement, John Holdren, Assistant to the White House for science and technology.

The project has an estimated value of about $ 18 billion in its first stage, about 3 billion dollars a year until 2017, said at press conference Bill Gerstenmaier, responsible for the newly created directory operations and human exploration from NASA (HEO, for its acronym in English).

Gerstenmaier acknowledged that it will be difficult to build, but it will give to NASA “the capacity to go beyond low Earth orbit and that no other country has succeeded”. He said that the plan has been calculated with sufficient flexibility so that when the Government reduced the budget of NASA, the Agency can continue working on this project.

The Senator Kay Bailey of Texas, whose state is home to one of the main centers of NASA in Houston, said: “this is what you were expecting to see long time”.

Computer-generated artist’s impression provided by NASA showing the space launch (SLS) system. EFE/NASA

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips